Emerging research also implicates the neurotransmitter glutamate in the development of ADHD, likely due to its interaction with dopamine and norepinephrine.
Thanks to Intuniv we have a new neurotransmitter to consider - and it must be considered in the context, as with any other ADHD med, of the Therapeutic Window.